Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 34.70 --0 (-0%)
Previous Close $34.70    52 Week High $34.07 
Open $34.70    52 Week Low $21.84 
Day High $34.70    P/E N/A 
Day Low $34.70    EPS $0.00 
Volume 8       

Regeneron (NASDAQ: REGN) Delayed: 612.14 +0.66 (0.11%)
Previous Close $611.48    52 Week High $592.36 
Open $613.11    52 Week Low $325.35 
Day High $616.55    P/E 160.67 
Day Low $605.01    EPS $3.81 
Volume 717,681       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 34.63 +0.07 (0.20%)
Previous Close $34.56    52 Week High $66.55 
Open $34.81    52 Week Low $37.82 
Day High $34.88    P/E N/A 
Day Low $33.88    EPS $0.00 
Volume 5,928,084